<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-O7LMYJSX/df1fa6c0-6213-4521-bfc2-a4d1f5b38aeb/PDF"><dcterms:extent>5825 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-O7LMYJSX/98618abf-e6cb-4865-a37d-1cd06bfd51a7/TEXT"><dcterms:extent>51 KB</dcterms:extent></edm:WebResource><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-O7LMYJSX"><dcterms:issued>2026</dcterms:issued><dc:creator>Cindrič, Helena</dc:creator><dc:creator>Davalos, Rafael V.</dc:creator><dc:creator>Deschamps, Frederic</dc:creator><dc:creator>Gehl, Julie</dc:creator><dc:creator>Kos, Bor</dc:creator><dc:creator>Kramar, Peter</dc:creator><dc:creator>Kuhelj, Dimitrij</dc:creator><dc:creator>Meijerink, Martijn R.</dc:creator><dc:creator>Miklavčič, Damijan</dc:creator><dc:creator>Serša, Gregor</dc:creator><dc:creator>Soden, Declan M.</dc:creator><dc:creator>Štabuc, Miha</dc:creator><dc:format xml:lang="sl">številka:3</dc:format><dc:format xml:lang="sl">letnik:60</dc:format><dc:format xml:lang="sl">str. 307-322</dc:format><dc:identifier>DOI:10.2478/raon-2026-0040</dc:identifier><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>COBISSID_HOST:287787523</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-O7LMYJSX</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Croatian Medical Association - Croatian Society of Radiology</dc:publisher><dc:publisher xml:lang="sl">Slovenian Medical Society - Section of Radiology</dc:publisher><dc:source xml:lang="sl">Radiology and oncology (Ljubljana)</dc:source><dc:subject xml:lang="sl">ablacija s pulzirajočim poljem</dc:subject><dc:subject xml:lang="sl">electrochemotherapy</dc:subject><dc:subject xml:lang="sl">electroporation</dc:subject><dc:subject xml:lang="sl">elektrokemoterapija</dc:subject><dc:subject xml:lang="sl">elektroporacija</dc:subject><dc:subject xml:lang="sl">gene electrotransfer</dc:subject><dc:subject xml:lang="sl">genska elektrotransfekcija</dc:subject><dc:subject xml:lang="sl">ireverzibilna elektroporacije</dc:subject><dc:subject xml:lang="sl">irreversible electroporation</dc:subject><dc:subject xml:lang="sl">pulsed field ablation</dc:subject><dc:title xml:lang="sl">Non-thermal ablation and drug delivery by electroporation| expanding current indications beyond cancer and cardiac treatment|</dc:title><dc:description xml:lang="sl">Background. Electroporation-Based Treatments and Therapies (EBTTs) – electrochemotherapy, irreversible electroporation, pulsed field ablation, and gene electro-transfer – use short, high-voltage electric pulses to permeabilize cell membranes, enabling non-thermal tissue ablation and enhanced local drug delivery. Although EBTTs have been used clinically for over three decades, primarily in oncology, their adoption remains limited compared to thermal ablation modalities. In contrast, cardiac pulsed field ablation (PFA) has seen rapid adoption since the first FDA device approval in December 2023. Conclusions. This expert opinion paper reviews the current clinical landscape of EBTTs in oncology and cardiac arrhythmia treatments, and focuses on emerging non-oncological and non-cardiac applications, including endoscopic pulsed electric field therapy for type 2 diabetes, bronchial rheoplasty for chronic bronchitis, bleomycin electrosclerotherapy for vascular malformations, nanosecond PFA for benign thyroid nodules, and electroporation-mediated gene delivery – and identifies key barriers to wider adoption: insufficient randomized evidence, lack of validated treatment planning tools, fragmented reimbursement, and limited standardization. We outline measures to facilitate clinical translation</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-O7LMYJSX"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-O7LMYJSX" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-O7LMYJSX/df1fa6c0-6213-4521-bfc2-a4d1f5b38aeb/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo radiologije in onkologije</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-O7LMYJSX/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-O7LMYJSX" /></ore:Aggregation></rdf:RDF>